Pamela A. Davol - Concepedia

Author

Pamela A. Davol

Roger Williams Medical Center

Also Known As

Pamela A Davol, Pamela A. Davol, Pamela Davol

Publications

705

Citations

H-Index

Concepts

All Affiliations

Roger Williams Medical Center Brown University Providence College Boston University University of California, San Francisco

About

Pamela A. Davol is an author at Roger Williams Medical Center specializing in medicine, immunotherapy, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	290
2	Immunology	3	3	205
3	Cell Biology	2	2	177
4	Engineering	1	1	72
5	Pathology	1	1	72

Pamela A. Davol

Publications

612

Citations

H-Index

Page 1

	Year	Citations
Anti-CD3 × Anti-Epidermal Growth Factor Receptor (EGFR) Bispecific Antibody Redirects T-Cell Cytolytic Activity to EGFR-Positive Cancers <i>In vitro</i> and in an Animal Model Ursula Reusch, Magesh Sundaram, Pamela A. Davol, Clinical Cancer Research Tumor Growth DelayImmunologyImmunoeditingImmunotherapeuticsImmunotherapy	2006	105
Antibody Targeting of Stem Cells to Infarcted Myocardium Randall J. Lee, Qizhi Fang, Pamela A. Davol, Stem Cells	2006	84
Human T Cells Armed with Her2/neu Bispecific Antibodies Divide, Are Cytotoxic, and Secrete Cytokines with Repeated Stimulation Ryan C. Grabert, Leslie P. Cousens, Janelle A. Smith, Clinical Cancer Research	2006	79
Shc proteins are strong, independent prognostic markers for both node-negative and node-positive primary breast cancer. Pamela A. Davol, Robert Bagdasaryan, Gerald J. Elfenbein, PubMed Breast OncologyEngineeringPathologyExperienced RelapseCancer Biology	2003	72
T cells armed with anti-CD3 × anti-CD20 bispecific antibody enhance killing of CD20+ malignant B cells and bypass complement-mediated rituximab resistance in vitro Jonathan M. Gall, Pamela A. Davol, Ryan C. Grabert, Experimental Hematology Cancer ImmunosurveillanceT CellsImmune RegulationTumor ImmunityImmunology	2005	61
Anti-CD3 × Anti-HER2 Bispecific Antibody Effectively Redirects Armed T Cells to Inhibit Tumor Development and Growth in Hormone-Refractory Prostate Cancer–Bearing Severe Combined Immunodeficient Beige Mice Pamela A. Davol, Janelle A. Smith, Nicola Kouttab, Clinical Prostate Cancer Tumor ImmunologyCancer ImmunosurveillanceImmunologyTumor ImmunityT Cell Immunity	2004	39
Redirected T‐cell cytotoxicity to epithelial cell adhesion molecule‐overexpressing adenocarcinomas by a novel recombinant antibody, E3Bi, in vitro and in an animal model Lifen Ren‐Heidenreich, Pamela A. Davol, Nicola Kouttab, Cancer	2004	33
Targeting human prostatic carcinoma through basic fibroblast growth factor receptors in an animal model: Characterizing and circumventing mechanisms of tumor resistance Pamela A. Davol, A. Raymond Frackelton The Prostate	1999	28
Targeting human CD34<sup>+</sup> hematopoietic stem cells with anti-CD45 × anti-myosin light-chain bispecific antibody preserves cardiac function in myocardial infarction Ting C. Zhao, Andy Tseng, Naohiro Yano, Journal of Applied Physiology	2008	27
p66 Shc and tyrosine-phosphorylated Shc in primary breast tumors identify patients likely to relapse despite tamoxifen therapy A. Raymond Frackelton, Lu Li, Pamela A. Davol, Breast Cancer Research	2006	23

Page 1